Research Square · Sep 25, 2026

Alveolar Bone Mineral Density Correlates with Lumbar Spine Bone Mineral Density During Romosozumab Therapy: A Prospective Observational Study In Osteoporosis

By Yamada H, Yoshida R, Hirosue A et al.

Abstract Early osteoporosis detection remains challenging because of the limited accessibility of dual-energy X-ray absorptiometry (DXA), sparking interest in the use of routine dental radiographs to assess alveolar bone mineral density (al-BMD). This prospective observational study evaluated the longitudinal changes in al-BMD during osteoporosis therapy, its association with systemic BMD and its utility as a screening and monitoring tool in female patients. al-BMD was quantified using standardized intraoral radiographs with reference phantoms, while systemic BMD and bone turnover markers were concurrently monitored. At baseline, al-BMD was significantly lower in patients with untreated osteoporosis than in both young and elderly non-osteoporotic controls. Receiver operating characteristic analysis demonstrated high diagnostic performance for al-BMD in identifying untreated osteoporosis, showing a positive correlation with the lumbar spine BMD but not with the femoral neck BMD and the total hip BMD. During sequential bone-anabolic therapy, al-BMD significantly increased over time, eventually reaching levels comparable to those of elderly non-osteoporotic controls. Also, al-BMD changes like those observed in systematic BMD. These findings suggest that al-BMD derived from dental radiographs is a clinically promising adjunct for osteoporosis screening and monitoring treatment-associated bone improvements.

doi.org/10.21203/rs.3.rs-10663648/v1Open accessBiomarkers

AgingResearch.News